Clinical trial
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients…
NCT00196846 · GBG Forschungs GmbH, Other · Completed
Key facts
| NCT number | NCT00196846 |
|---|---|
| Title | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) |
| Official title | Prospective Randomized Multicenter Study to Prevent Chemotherapy Induced Ovarian Failure With the GnRH-Agonist Goserelin in Young Hormone Insensitive Breast Cancer Patients Receiving Anthracycline Containing (Neo-)Adjuvant Chemotherapy |
| Lead sponsor | GBG Forschungs GmbH, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Goserelin |
| Enrollment | 62 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Mar 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 14, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: